332 results on '"Fung, Chunkit"'
Search Results
102. Pharmacokinetic (PK) modeling of serum platinum to reveal extent of long-term exposure and associated comorbidities after cisplatin treatment.
103. A systematic review of randomized controlled trials (RCTs) of exercise interventions using digital activity trackers (E-DAT) in cancer patients.
104. Exercise for Toxicity Management in Cancer—A Narrative Review
105. Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
106. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma
107. Novel Therapies in Platinum-refractory Metastatic Germ Cell Tumor: A Case Report with a Focus on a PD-1 Inhibitor
108. Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity
109. Effect of exercise on quality of life (QoL) in 198 older patients with cancer: A URCC NCORP nationwide RCT.
110. Feasibility of utilizing a novel mhealth platform to deliver an evidence-based exercise intervention among testicular cancer survivors (TCS).
111. A phase II RCT of high-dose vitamin D supplementation for androgen deprivation therapy (ADT)-induced bone loss among older prostate cancer (PCa) patients.
112. Effects of exercise on dyspnea and cancer-related fatigue in patients with prostate cancer.
113. A phase II study of enzalutamide (Enz) with dutasteride (Dut) or finasteride (Fin) in men ≥ 65 years with hormone-naive systemic prostate cancer (HNSPCa).
114. Biopsychosocial distress assessment among testicular cancer survivors (TCS) using electronic patient reported outcomes (PROs).
115. Feasibility of an electronic implementation method of an evidence-based exercise intervention among testicular cancer survivors (TCS).
116. An integrative approach to personalized cancer survivorship care at an academic medical center.
117. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study
118. Bladder cancer in the elderly patient: challenges and solutions
119. Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
120. Targeted Therapy Based on Tumor Genomic Analyses in Metastatic Urachal Carcinoma
121. Genome-wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors.
122. Management and outcomes of patients with renal medullary carcinoma (RMC): A collaborative multi-center study of 52 patients.
123. Variation in protein-coding sequence and the genetic basis of cisplatin-induced toxicities among testicular cancer survivors (TCS) in the Platinum Study.
124. Reply to S. Alanee et al
125. Psychotropic and stimulant medication (PSM) use among testicular cancer survivors (TCS): A multi-institutional clinical study of 680 patients given cisplatin-based chemotherapy (CHEM) (NCI 1R01 CA157823-02).
126. Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study
127. Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.
128. A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.
129. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
130. The impact of population pharmacogenomics and risk allele frequencies on cisplatin-induced peripheral sensory neuropathy (PSN).
131. Secondary malignant neoplasms in testicular cancer survivors
132. Association of falls with health related quality of life (HRQOL) in older cancer patients: A population based longitudinal study.
133. Management and outcomes of patients with renal medullary carcinoma (RMC): A multicenter retrospective study of 39 patients.
134. Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.
135. Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis
136. Prostate Cancer in the Elderly Patient
137. Cardiovascular mortality (CVM) among testicular nonseminoma (TN) survivors after chemotherapy (CHEM) or surgery (SURG).
138. Reply to G. Gandaglia et al
139. A Case Series of Transformation of Teratoma to Primitive Neuroectodermal Tumor: Evolving Management of a Rare Malignancy
140. Changes in health-related quality of life (HRQL) after bladder cancer (BC) diagnosis (DX): A longitudinal population-based study.
141. Solid Tumors After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study
142. Impact of bladder cancer (BC) on health-related quality of life (HRQL) in 1,476 older Americans.
143. Characteristics and outcomes of elderly patients with systemic prostate cancer (PCa) treated with peripheral androgen blockade (PAB).
144. Second malignant neoplasms (SMN) among 18,627 testicular cancer survivors (TCS) after chemotherapy (CHEM) or surgery (SURG).
145. Second Malignant Neoplasms in Testicular Cancer Survivors
146. Association of GSTP1, COMT, and TPMT with testicular cancer (TC) treatment outcome after cisplatin-based chemotherapy (CBCT).
147. Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF)
148. Adjuvant and Neoadjuvant Therapies in High-Risk Renal Cell Carcinoma
149. Feasibility Of An Evidence-based Exercise Intervention With Electronic Medical Record Integration For Testicular Cancer Survivors: 348.
150. Long-term Morbidity of Testicular Cancer Treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.